225 related articles for article (PubMed ID: 35858935)
1. Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma.
Zheng Y; Jia R; Li J; Tian X; Qian Y
J Nanobiotechnology; 2022 Jul; 20(1):339. PubMed ID: 35858935
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
7. Development of curcumin-loaded galactosylated chitosan-coated nanoparticles for targeted delivery of hepatocellular carcinoma.
Huang M; Liu J; Fan Y; Sun J; Cheng JX; Zhang XF; Zhai BT; Guo DY
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127219. PubMed ID: 37802456
[TBL] [Abstract][Full Text] [Related]
8. Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation.
Rahman M; Almalki WH; Afzal O; Alfawaz Altamimi AS; Kazmi I; Al-Abbasi FA; Choudhry H; Alenezi SK; Barkat MA; Beg S; Kumar V; Alhalmi A
Int J Nanomedicine; 2020; 15():9283-9299. PubMed ID: 33262588
[TBL] [Abstract][Full Text] [Related]
9. SP94 Peptide-Functionalized PEG-PLGA Nanoparticle Loading with Cryptotanshinone for Targeting Therapy of Hepatocellular Carcinoma.
Nie X; Liu Y; Li M; Yu X; Yuan W; Huang S; Ren D; Wang Y; Wang Y
AAPS PharmSciTech; 2020 Apr; 21(4):124. PubMed ID: 32342227
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
[TBL] [Abstract][Full Text] [Related]
11. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
13. Dual-Targeting Nanoparticles: Codelivery of Curcumin and 5-Fluorouracil for Synergistic Treatment of Hepatocarcinoma.
Ni W; Li Z; Liu Z; Ji Y; Wu L; Sun S; Jian X; Gao X
J Pharm Sci; 2019 Mar; 108(3):1284-1295. PubMed ID: 30395829
[TBL] [Abstract][Full Text] [Related]
14. Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer.
Deng L; Zhu X; Yu Z; Li Y; Qin L; Liu Z; Feng L; Guo R; Zheng Y
Int J Nanomedicine; 2020; 15():7745-7762. PubMed ID: 33116498
[TBL] [Abstract][Full Text] [Related]
15. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma.
Zhao B; Dong Z; Liu W; Lou F; Wang Q; Hong H; Wang Y
J Nanobiotechnology; 2021 May; 19(1):124. PubMed ID: 33933077
[TBL] [Abstract][Full Text] [Related]
17. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
[TBL] [Abstract][Full Text] [Related]
18. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
[TBL] [Abstract][Full Text] [Related]
19. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
Zhao P; Li M; Wang Y; Chen Y; He C; Zhang X; Yang T; Lu Y; You J; Lee RJ; Xiang G
Acta Biomater; 2018 May; 72():248-255. PubMed ID: 29555460
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma.
Elnaggar MH; Abushouk AI; Hassan AHE; Lamloum HM; Benmelouka A; Moatamed SA; Abd-Elmegeed H; Attia S; Samir A; Amr N; Johar D; Zaky S
Semin Cancer Biol; 2021 Feb; 69():91-99. PubMed ID: 31421265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
